John Michael McCarty, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

University Of Washington School Of Medicine - Seattle WA
Rank: Instructor
Years: 1992-1996

Virginia Commonwealth University School Of Medicine (Previously MCV) - Richmond VA
Rank: Assistant Professor
Years: 1996-present

None Reported

The influence of lymphoid reconstitution kinetics on clinical outcomes in allogeneic stem cell transplantation
Leukemia Lymphoma
Volume: 59(12)
Date: 12 2018

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): A global, double-blind, randomised, phase 3 trial.
Lancet
393(101068)
Date: 01 2019

Effect of aging and predonation cormorbidities on the realted peripheral blood stem cell donor experience: Report from the related donor safety study
Biol Blood Marrow Transplant
Volume: 25(4)
Date: 04 2019

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year comparted to unrelated donors
Haematologica
Volume: 104(4)
Date: 04 2019

Managing post allograft relapse of myeloid neoplasms: azacytidine and donor lymhpocyte infusions as salvage therapy
Leulemia Lymphoma
Volume: 60(11)
Date: 11 2019

Bronchoalveoloar Lavage to evaluate new pulmonary infiltrates in allogeneic hematopoietic stem cell transplant recipients: Impact on antimicrobial optimization
Infection Prevention practice
Volume: 1(3):
Date: 12 2019

Killer Immunoglobulin-Like receptor-ligan interactions prodict clinical outcomes following unrelated donor transplantations
Biol Blood Marrow Transplant
Volume: 26(4)
Date: 04 2020

National Marrow Donor Program sponssored Multicenter Phase II trials of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation using post-transplan Cyclophosphamide
J Clin Oncology
39(18):1971-1982
Date: 06 2021

Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous hematopoietic cell transplantation
British Journal of Hematology
195(5):757-763
Date: 12 2021

Impact of Center Experience with Donor Type Outcomes: A secondary Analysis of BMTCTN 1101
Thransplant Cell Therapies
28(7):406
Date: 07 2022